Status:
COMPLETED
Evaluation of the New Variant 501Y.V2 of COVID-19
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Collaborating Sponsors:
Central Hospital, Nancy, France
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
In January 2021, the incidence of COVID-19-and its mortality started rising for the third time in France. This rise may associate with three emerging variants, namely, V1, V2, and V3, which are the 20...
Eligibility Criteria
Inclusion
- Admission in ICU in February, March or April 2021
- Patient with a SARS-CoV-2 positive polymerase-chain reaction test
- Patient with 20I/501Y.V1 ("English") or 20H/501Y.V2 ("South African") SARS-CoV-2 variants
Exclusion
- Opposed to use data
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2021
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04906850
Start Date
March 1 2021
End Date
May 15 2021
Last Update
June 2 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Nancy, Meurthe-et-moselle, France, 54000
2
CHR Metz Thionville
Metz, Moselle, France, 57085